Ascendis Pharma A/s (ASND) Technical Analysis
$216.92
Market is closed - opens 7 PM, 30 Mar 2026
Insights
- Ascendis Pharma A/s is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Ascendis Pharma A/s stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Ascendis Pharma A/s stock is Range bound.
- Based on analysis of the Pivot Points, the current market trend for Ascendis Pharma A/s stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 40.3 | Neutral |
Stochastic | 13.18, 20.85 | Neutral |
Ultimate Oscillator | 30.3 | Neutral |
Stochastic Relative Strength Index | 22.69, 16.81 | Neutral |
Moving Average Convergence Divergence | -2.7, -0.87 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 222.42 | Sell |
20 | 229.39 | Buy |
50 | 226.51 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 222.06 | Sell |
20 | 225.13 | Buy |
50 | 224.33 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 223.32 | Neutral |
20 | 231.9 | Sell |
50 | 226.49 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 217.66 | Sell |
20 | 222.27 | Sell |
50 | 229.1 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 216.27 | Sell |
20 | 217.88 | Sell |
50 | 227.81 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 253.39 |
Resistance L2 | 245.6 |
Resistance L1 | 233.1 |
Pivot Point | 225.31 |
Support L1 | 212.81 |
Support L2 | 205.02 |
Support L3 | 192.52 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.